These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19578135)

  • 1. Comment on: British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years).
    McLaren ZL; Abernethy VE; Dawson JK
    Rheumatology (Oxford); 2009 Sep; 48(9):1178-9; author reply 1179. PubMed ID: 19578135
    [No Abstract]   [Full Text] [Related]  

  • 2. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years).
    Luqmani R; Hennell S; Estrach C; Basher D; Birrell F; Bosworth A; Burke F; Callaghan C; Candal-Couto J; Fokke C; Goodson N; Homer D; Jackman J; Jeffreson P; Oliver S; Reed M; Sanz L; Stableford Z; Taylor P; Todd N; Warburton L; Washbrook C; Wilkinson M; ;
    Rheumatology (Oxford); 2009 Apr; 48(4):436-9. PubMed ID: 19174570
    [No Abstract]   [Full Text] [Related]  

  • 3. British Society for Rheumatology and british health professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years).
    Luqmani R; Hennell S; Estrach C; Birrell F; Bosworth A; Davenport G; Fokke C; Goodson N; Jeffreson P; Lamb E; Mohammed R; Oliver S; Stableford Z; Walsh D; Washbrook C; Webb F; ;
    Rheumatology (Oxford); 2006 Sep; 45(9):1167-9. PubMed ID: 16844700
    [No Abstract]   [Full Text] [Related]  

  • 4. The case against haste in the treatment of rheumatoid arthritis: comment on the editorial by Pincus et al.
    Epstein WV
    Arthritis Rheum; 2003 Feb; 48(2):573-5; author reply 576-9. PubMed ID: 12571870
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
    Bhalla AK; Samaranayaka M
    Rheumatology (Oxford); 2008 Oct; 47(10):1591; author reply 1591. PubMed ID: 18676499
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of rheumatoid arthritis in primary care--an educational need?
    Wise EM; Isaacs JD
    Rheumatology (Oxford); 2005 Nov; 44(11):1337-8. PubMed ID: 16105914
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on: Modelling the cost effectiveness of TNF antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.
    van Vollenhoven RF;
    Rheumatology (Oxford); 2008 Jul; 47(7):1106-7; author reply 1107. PubMed ID: 18326533
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statement of the German Society of Rheumatology (DGRh) reporting on the Institute's plan for biologicals in the second-line therapy for rheumatoid arthritis].
    Braun J; Krüger K; Genth E
    Z Rheumatol; 2011 Dec; 70(10):882-3. PubMed ID: 22139207
    [No Abstract]   [Full Text] [Related]  

  • 9. Should rheumatoid arthritis be treated conservatively or aggressively?
    Breedveld FC
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii41-3. PubMed ID: 12817095
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is the guideline, "Management of early rheumatoid arthritis," being followed in a rheumatism center?].
    Hartmann M; Gundermann C; Richter A; Eidner T; Hein G
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1721-4. PubMed ID: 18696403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again).
    Deighton CM; George E; Kiely PD; Ledingham J; Luqmani RA; Scott DG
    Rheumatology (Oxford); 2006 Jun; 45(6):649-52. PubMed ID: 16527881
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2009 May; 7(81):37-46; quiz 47-8. PubMed ID: 19390497
    [No Abstract]   [Full Text] [Related]  

  • 14. [Standardization of methotrexate administration in routine rheumatological practice].
    Murav'ev IuV
    Ter Arkh; 2011; 83(5):33-7. PubMed ID: 21780654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The British Society for Rheumatology Biologics Register: 6 years on.
    Hyrich KL; Watson KD; Isenberg DA; Symmons DP;
    Rheumatology (Oxford); 2008 Oct; 47(10):1441-3. PubMed ID: 18596052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Levamisole used in rheumatoid arthritis].
    Veys EM; Mielants H
    Acta Rhumatol; 1979; 3(3):219-30. PubMed ID: 11496645
    [No Abstract]   [Full Text] [Related]  

  • 17. How to dose infliximab in rheumatoid arthritis: new data on a serious issue.
    van Vollenhoven RF
    Ann Rheum Dis; 2009 Aug; 68(8):1237-9. PubMed ID: 19605741
    [No Abstract]   [Full Text] [Related]  

  • 18. When and for how long should glucocorticoids be used in rheumatoid arthritis? International guidelines and recommendations.
    Gaujoux-Viala C; Gossec L
    Ann N Y Acad Sci; 2014 May; 1318():32-40. PubMed ID: 24827544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on: Multicentre survey of rheumatoid arthritis patients from Ministry of Health rheumatology centres in Malaysia.
    Yeap SS
    Int J Rheum Dis; 2009 Jul; 12(2):177-8; author reply 179. PubMed ID: 20374340
    [No Abstract]   [Full Text] [Related]  

  • 20. [The practice guideline 'Rheumatoid arthritis' (first revision) from the Dutch College of General Practitioners: a response from the perspective of rheumatology].
    Bijlsma JW; Jacobs JW
    Ned Tijdschr Geneeskd; 2004 Mar; 148(12):557-8. PubMed ID: 15074176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.